Leukemia: all 5,475 studies
Page 40 of 55. Open to participants first (629), then studies with results posted, then the rest; newest registration first within each.
- Phase II Study for Safety and Efficacy Evaluation of Imatinib Mesylate in Children With Chronic Myeloid Leukemia (CML) Philadelphia Chromosome-positive (Ph+)Status unknownNCT01221376Phase 2
- Determining the Maximum Tolerated Dose of Low Dose Interferon-alpha in Conjunction With Nilotinib in Pretreated Philadelphia Chromosome Positive (Ph+) Chronic Myeloid Leukemia Patients in Chronic Phase (CML-CP)CompletedNCT01220648Phase 1
- A Study Investigating the Predictive Value of Philadelphia Positive Stem Cell Properties in Newly Diagnosed Patients With Chronic Myeloid Leukemia in Chronic Phase Receiving Treatment With ImatinibCompletedNCT01215487
- Early Detection of Anthracycline Cardiotoxicity by Echocardiographic Analysis of Myocardial Deformation in 2D StrainCompletedNCT01212926Not applicable
- Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL)CompletedNCT01212380Phase 1
- Study of Sapacitabine in Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS)Status unknownNCT01211457Phase 1/2
- A Study of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia And DCDT2980S in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non Hodgkin's LymphomaCompletedNCT01209130Phase 1
- Optimized Radiological Diagnosis of Hepatic Candidiasis During the Treatment of Acute LeukemiasCompletedNCT01207843
- AHN-12 Biodistribution in Advanced LeukemiaTerminatedNCT01207076Phase 1
- Prospective Pilot Study of Bone Marrow and Peripheral Blood Samples From AML Patients to Characterize the Biologic Heterogeneity of the Disease Using Single Cell Network Profiling (SCNP)CompletedNCT01203033
- Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell TransplantNo longer availableNCT01200017
- A Study of Clofarabine in Japanese Paediatric Patients With Relapsed or Refractory Acute Lymphoblastic LeukaemiaCompletedNCT01196013Phase 1
- Study the Novel Functions and Molecular Mechanisms of Vascular Endothelial Growth Factor-C (VEGF-C) in Acute Myeloid Leukemia (AML)Status unknownNCT01195506
- CD19-CAR Immunotherapy for Childhood Acute Lymphoblastic Leukemia (ALL)TerminatedNCT01195480Phase 1/2
- RAD001 in Patients With Chronic Phase Chronic Myeloid Leukemia w/ Molecular Disease.WithdrawnNCT01188889Phase 1/2
- Program of Evaluation and Geriatric Intervention on the Functional Status, Quality of the Life, and SurvivalStatus unknownNCT01188330Not applicable
- Fenretinide in Children With Recurrent/Resistant ALL, AML, and NHLTerminatedNCT01187810Phase 1
- Combined Immunochemotherapy in Patients With T-Prolymphocytic Leukemia (T-PLL)CompletedNCT01186640Phase 2
- Study of Blood and Tissue Samples in Children With Newly Diagnosed Acute Lymphoblastic LeukemiaStatus unknownNCT01185886
- Activity & Safety Study of Lenalidomide & Rituximab as Non-chemotherapy Based Therapy on Chronic Lymphocytic LeukemiaCompletedNCT01185262Phase 1
- A Phase I Study of SB939 in Pediatric Patients With Refractory Solid Tumours and LeukemiaCompletedNCT01184274Phase 1
- Extension Study With Tosedostat in Relapsed/Refractory Acute Myeloid LeukemiaStatus unknownNCT01180426Phase 2
- High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin LymphomaCompletedNCT01177371Phase 2
- Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic MalignanciesCompletedNCT01175785Phase 2
- Test Extracorporeal Photopheresis (ECP) Treatment Before/After Allogeneic Bone Marrow Transplant (BMT) or Peripheral Blood Stem Cell (PBSC) Transplant to Prevent Graft Versus Host DiseaseCompletedNCT01174940Early Phase 1
- Phase I Combination of Midostaurin, Bortezomib, and Chemo in Relapsed/Refractory Acute Myeloid LeukemiaCompletedNCT01174888Phase 1
- Collection of Blood and/or Bone Marrow for Investigation and Characterization of Normal and Abnormal Cell GrowthWithdrawnNCT01174615
- Biomarkers in Bone Marrow and Blood Samples From Older Patients With Acute Myeloid Leukemia Treated With Cytarabine-Based TherapyCompletedNCT01169363
- A Phase I, Multicenter, Open-label, Dose-escalation Study to Assess the Safety of Lenalidomide in Patients With Advanced Adult T-cell Leukemia-lymphoma and Peripheral T-cell Lymphomaperipheral T-cell LymphomaCompletedNCT01169298Phase 1
- PK Study of Oral and IV Clofarabine in High Risk Myelodysplasia+Acute LeukemiasCompletedNCT01169012Phase 1
- Safety and Efficacy of 72-hour and 120-hour Infusion of Rigosertib in Acute Myeloid Leukemia (AML) and Acute Lymphoid Leukemia (ALL)CompletedNCT01167166Phase 1/2
- Nelfinavir Mesylate and Bortezomib in Treating Patients With Relapsed or Progressive Advanced Hematologic CancerCompletedNCT01164709Phase 1
- INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative DiseaseCompletedNCT01164163Phase 1
- T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic MalignanciesWithdrawnNCT01163201Phase 1/2
- Phase II Study of VELCADE for Relapsed or Refractory T-cell Prolymphocytic LeukemiaWithdrawnNCT01162031Phase 2
- Safety and Tolerability of XmAb®5574 in Chronic Lymphocytic LeukemiaCompletedNCT01161511Phase 1
- Entinostat and Sorafenib Tosylate in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory or Relapsed Acute Myeloid LeukemiaTerminatedNCT01159301Phase 1
- Clinical Trial of BP1001 (L-Grb-2 Antisense Oligonucleotide) in CML, AML, ALL & MDSCompletedNCT01159028Phase 1
- RO4929097 and Capecitabine in Treating Patients With Refractory Solid TumorsCompletedNCT01158274Phase 1
- Combination Chemotherapy in Treating Young Adult Patients With Acute Lymphoblastic LeukemiaCompletedNCT01156883Not applicable
- Everolimus MICE-regimen in Treating Older Patients With Newly Diagnosed Acute Myeloid LeukemiaCompletedNCT01154439Phase 1
- Lestaurtinib With or Without Chemotherapy Agents in Samples From Young Patients With LeukemiaCompletedNCT01150669
- Obatoclax Mesylate in Samples From Young Patients With Acute Myeloid LeukemiaCompletedNCT01150656
- Drug Biomarkers in Cell Samples From Patients With Acute Myeloid LeukemiaCompletedNCT01150058
- Study of Hypoxia-Activated Prodrug TH-302 to Treat Advanced LeukemiasCompletedNCT01149915Phase 1
- Decitabine Maintenance in Elderly Acute Myeloid Leukemia PatientsCompletedNCT01149408Phase 1
- Quality of Life Study for Adult Patients With Acute Lymphoblastic LeukemiaCompletedNCT01148927
- Pharmacokinetic Profile of Vincristine Administered With Imatinib for Bcr-Abl Positive Acute Lymphoblastic Leukemia (ALL) Compared to That Without Imatinib for Bcr-Abl Negative ALLTerminatedNCT01148134
- Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)CompletedNCT01147939Phase 3
- Autologous Hematopoietic Cell Transplantation for Core-binding Factor (CBF) Acute Myeloid Leukemia (AML) in the First Complete Remission (CR1)Status unknownNCT01146977Phase 2
- Vaccination by Leukemic Apoptotic Corpse Autologous Pulsed Dendritic Cells for Acute Myelogenous Leukemia (AML) Patients in First or Second Complete Remission (CR)(CD laM)Status unknownNCT01146262Phase 1/2
- Biomarkers in Bone Marrow Samples From Patients With Acute Promyelocytic LeukemiaCompletedNCT01146223
- Identification of de Novo Fanconi Anemia in Younger Patients With Newly Diagnosed Acute Myeloid LeukemiaCompletedNCT01146210
- Idarubicin Versus High Dose Daunorubicin in Acute Myelogenous Leukemia (AML)Status unknownNCT01145846Phase 3
- Biomarkers in DNA Samples From Patients With Chronic Lymphocytic Leukemia Previously Treated With Fludarabine-Based TherapyCompletedNCT01145469
- Biomarker To Evaluate Protein Profiles of Neutropenic Fever/Infection With Acute or Chronic LeukemiasCompletedNCT01144793
- Study of Bafetinib as Treatment for Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)CompletedNCT01144260Phase 2
- Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT01142427
- Development and Exploration of the Feasibility of Using Locally Synthesized Small Molecule Inhibitors to Treat Human Acute Leukemia CellsStatus unknownNCT01142375
- Development of a Diagnostic Kit for FLT3-ITD in Acute Myeloid LeukemiaStatus unknownNCT01141673
- Biomarker Changes in Samples From Young Patients With Acute Myeloid LeukemiaCompletedNCT01139931
- Specimen Collection for Agricultural Health Study Cohort Pesticide Exposure StudyCompletedNCT01139476
- Blood and Tumor Tissue Samples From Young Patients With Acute Myeloid LeukemiaCompletedNCT01139333
- Biomarkers in DNA Samples From Younger Patients With Newly Diagnosed Acute Myeloid Leukemia Receiving Gemtuzumab OzogamicinCompletedNCT01139320
- Biomarkers in Samples From Patients With Down Syndrome and Acute Megakaryoblastic LeukemiaCompletedNCT01139307
- 4'-Thio-araC (Thiarabine) in Advanced Hematologic MalignanciesCompletedNCT01139151Phase 1
- Study of the Trifunctional Antibody FBTA05 and Donor Lymphocyte Infusion in B-cell Lymphoma After Allogeneic Stem Cell TransplantationWithdrawnNCT01138579Phase 1/2
- Biomarkers in Young Patients With Acute Myeloid LeukemiaCompletedNCT01138332
- Biomarkers in Patients With Acute Myeloid LeukemiaCompletedNCT01138319
- Biomarkers in Samples From Young Patients With Acute Myeloid LeukemiaCompletedNCT01138306
- Carfilzomib in Patients With Relapsed Acute Myeloid or Acute Lymphoblastic LeukemiaCompletedNCT01137747Phase 1
- Use of Decitabine in Myelodysplastic Syndrome (MDS) Following Azacitidine (AZA) FailureStatus unknownNCT01133886Phase 2
- Open-Label Study of Lenalidomide in Combination With Oral Dexamethasone in the Treatment of Previously Untreated, Symptomatic Patients With Chronic Lymphocytic LeukemiaCompletedNCT01133743Phase 2
- Lenalidomide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid LeukemiaCompletedNCT01132586Phase 1
- Entinostat and Clofarabine in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Poor-Risk Acute Lymphoblastic Leukemia or Bilineage/Biphenotypic LeukemiaCompletedNCT01132573Phase 1
- PH2 Trial in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) With a Combination of Bendamustine & OfatumumabWithdrawnNCT01131247Phase 2
- Safety of Zileuton (Zyflo) in Combination With Imatinib Mesylate (Gleevec) in CML.TerminatedNCT01130688Phase 1
- Combination of Decitabine and Midostaurin in Patients Older Than 60 With Newly Diagnosed or Relapsed Refractory Acute Myeloid LeukemiaCompletedNCT01130662Phase 1
- Decitabine, Vorinostat, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic SyndromeCompletedNCT01130506Phase 1
- AR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or LymphomaCompletedNCT01129193Phase 1
- Bortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell LymphomaCompletedNCT01129180Phase 1
- RESPeCT: Revlimid Early Stage Poor Prognosis Chronic Lymphocytic Leukaemia (CLL) TrialTerminatedNCT01127542Phase 2
- Bortezomib, Mitoxantrone, Etoposide, and Cytarabine in Relapsed or Refractory Acute Myeloid LeukemiaCompletedNCT01127009Phase 1
- A Study of Nilotinib in Adult Patients With Imatinib Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic PhaseCompletedNCT01126892Phase 3
- A Study of Imatinib With Reinduction Chemotherapy Using Mitoxantrone, Etoposide and Cytarabine in Patients With Relapsed/Refractory C-kit Positive (AML) Acute Myeloid LeukemiaCompletedNCT01126814Phase 1/2
- Alvespimycin Hydrochloride in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-Cell Prolymphocytic LeukemiaTerminatedNCT01126502Phase 1
- Clinical Protocol for the Treatment of Patients With Previously Untreated Chronic Lymphocytic Leukemia With a Combination of Bendamustine and OfatumumabTerminatedNCT01125787Phase 2
- First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell CancersCompletedNCT01120457Phase 1
- Biomarkers in DNA Samples From Patients With High-Risk Acute Lymphoblastic LeukemiaCompletedNCT01119586
- Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)CompletedNCT01118234Phase 3
- International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic LeukemiaCompletedNCT01117441Phase 3
- Enrollment on the Childhood Cancer Research Network (CCRN) of the Children's Oncology GroupActive, not recruitingNCT01117168
- A Study of the Kinetics of Lymphoid Cells in Patients With Monoclonal B-cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL), Mantle Cell Lymphoma (MCL) and Healthy VolunteersCompletedNCT01117142
- Repeat-dose Study of Lenalidomide (Revlimid ®) Plus Dexamethasone in Patients With Lymphoblastic LeukemiaCompletedNCT01116193Phase 2
- Longitudinal Investigation of Hippocampal Function and Morphology in Acute Lymphatic Leukemia (ALL) Patients Treated With ChemotherapyStatus unknownNCT01111396
- Direct Measurement of Leukemic Cell Turnover (Synthesis and Removal) in Patients With Chronic Lymphocytic Leukemia (CLL) Using Deuterated WaterCompletedNCT01110850
- Prevention of Left Ventricular Dysfunction During ChemotherapyCompletedNCT01110824Phase 3
- ABT-348 as Monotherapy and in Combination With Azacitidine to Treat Advanced Hematologic MalignanciesCompletedNCT01110473Phase 1
- Ofatumumab Cardiac Repolarization (QTc) Study in Fludarabine-Refractory Chronic Lymphocytic Leukemia SubjectsCompletedNCT01110031Phase 1
- Bendamustine Hydrochloride Injection for Initial Treatment of Chronic Lymphocytic LeukemiaCompletedNCT01109264Phase 2